| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2
|
Brown, Zachary
|
|
|
24 |
9 |
p. 642-647
|
article
|
| 2 |
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet
|
Joks, Maria Magdalena
|
|
|
24 |
9 |
p. e293-e300
|
article
|
| 3 |
Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands
|
Bennink, Christine
|
|
|
24 |
9 |
p. 604-610
|
article
|
| 4 |
Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents
|
Garcia-Manero, Guillermo
|
|
|
24 |
9 |
p. e283-e292
|
article
|
| 5 |
Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the Molecular
|
Brazel, Danielle
|
|
|
24 |
9 |
p. 583-591
|
article
|
| 6 |
Editorial Board
|
|
|
|
24 |
9 |
p. A1-A2
|
article
|
| 7 |
Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome
|
Sasaki, Koji
|
|
|
24 |
9 |
p. 629-633
|
article
|
| 8 |
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma
|
Kirchberg, Janine
|
|
|
24 |
9 |
p. e277-e282
|
article
|
| 9 |
Long-Term Follow-Up of Patients With Follicular Lymphoma Using Next Generation Sequencing to Detect Minimal Residual Disease
|
Chauhan, Ayushi
|
|
|
24 |
9 |
p. 634-641
|
article
|
| 10 |
Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy
|
Handa, Shivani
|
|
|
24 |
9 |
p. e314-e319
|
article
|
| 11 |
Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry
|
Ghosh, Nilanjan
|
|
|
24 |
9 |
p. e301-e313
|
article
|
| 12 |
Retraction notice to ``P-377 CD38 targeting in multiple myeloma'' [Clinical Lymphoma Myeloma and Leukemia 23 Supplement 2 (2023) S248]
|
Abel, Andrea
|
|
|
24 |
9 |
p. 648
|
article
|
| 13 |
Risk of Infection in Patients With Multiple Myeloma Treated With T-Cell Redirecting Approaches: A Call Out for Clinicians
|
Lupia, Tommaso
|
|
|
24 |
9 |
p. 592-603
|
article
|
| 14 |
Second Line Therapy in Multiple Myeloma: A SEER Medicare Analysis
|
LeBlanc, Matthew R.
|
|
|
24 |
9 |
p. 611-620
|
article
|
| 15 |
SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes
|
Hochman, Michael J.
|
|
|
24 |
9 |
p. 573-582
|
article
|
| 16 |
SOHO State of the Art Updates and Next Questions | Novel Agents and the Diminishing Role of Allogeneic Stem Cell Transplant in B-Acute Lymphoblastic Leukemia
|
Jen, Wei-Ying
|
|
|
24 |
9 |
p. 565-572
|
article
|
| 17 |
Table of Contents
|
|
|
|
24 |
9 |
p. A3-A5
|
article
|
| 18 |
T Cell Exhaustion Markers in Multiple Myeloma Patients are Lower After Physical Activity Intervention
|
Joseph, Janine M.
|
|
|
24 |
9 |
p. 621-628
|
article
|
| 19 |
Unmet Needs in the First-Line Treatment of Diffuse Large B-cell Lymphoma: Expert Recommendations From the Asia-Pacific Region With a Focus on the Challenging Subtypes
|
Tan, Daryl
|
|
|
24 |
9 |
p. e320-e328
|
article
|
Journal description